Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti- inflammatory cytokines

Journal of Neuroimmunology

Volumn 85, Issue 2, 1998, Pages 146-154

  Diab, Asim ^a   Michael, Levi ^b   Wahren, Britt ^b   Deng, Guo Min ^a   Björk, Jakob ^c   Hedlund, Gunnar ^c,d   Zhu, Jie ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Pharmacia & Upjohn AB   (Sweden)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Autoimmunity; Cytokine; Experimental allergic encephalomyelitis; Linomide

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; ROQUINIMEX; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HELPER CELL; IN SITU HYBRIDIZATION; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD TRANSSECTION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYDROXYQUINOLINES; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, INBRED LEW; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0032524528     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00023-X     Document Type: Article

References (38)

1. Bai X.F., Shi F.D., Zhu J., Xiao B.G., Gunnar H., Link H. Linomide induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophages functions. J. Neuroimmunol. 76:1997;177-184.
2. Beck J., Rondot P., Catinot L., Falcoff E., Kirchner H., Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbation? Acta Neurol. Scand. 78:1988;318-323.
3. Ben-Nun A., Wekerle H., Cohen I. The rapid isolation of clonable antigen specific lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11:1981;195-199.
4. Bjork J., Kleinau S. Paradoxical effects of LS-2616 (linomide) treatment in the type II collagen arthritis model in mice. Agents Actions. 27:1989;319-321.
5. Brideau R.J., Carter P.B., McMaster W.R., Mason D.W., Williams A.F. Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur. J. Immunol. 10:1980;609-615.
6. Dagerlined, Å., Friberg, K., Bean, A.L., Hökfelt, T., 1992. Sensitive mRNA detection using unfixed tissue: Combined radioactive and non-radioactive in situ hybridization histochemistry, 98, 39-49.
7. Deibler G.E., Martensson R.E., Kies M.V. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:1972;139-165.
8. Derynck R., Jarrett J.A., Chen E.Y., Eaton D.H., Bell J.R., Assoian R.K., Roberts A.B., Sporn M.B., Goeddel D.V. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature. 316:1985;701-705.
9. Diab A., Zhu J., Xiao B.G., Mustafa M., Link H. High IL-6 and low IL-10 in the central nervous system is associated with chronic EAE in DA rats. J. Neuropathol. Exp. Neurol. 6:1997;641-650.
10. Dijkema R., van der Meide P.H., Dubbeld M., Wubben J., Schellekens H. Cloning expression and purification of rat IFN-γ Meth. Enzymol. 119:1986;453-463.
11. Duong T.T., St-Louis J., Gilbert J.J., Finkelman F.D., Strejan G.H. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36:1992;105-115.
12. Issazadeh S., Mustafa M., Ljungdahl Å., Höjeberg B., Dagerlind Å., Elde R., Olsson T. Interferon γ Interleukin 4 and transforming growth factor β in experimental allergic encephalomyelitis in Lewis rats; dynamics of cellular mRNA expression in the central nervous system and lymphoid cell. J. Neurosci. Res. 40:1995;579-590.
13. Issazadeh S., Ljungdahl Å., Höjeberg B., Mustafa M., Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor α and tumor necrosis factor β J. Neuroimmunol. 61:1995;205-212.
14. Johns L.D., Sriram S. Experimental autoimmune encephalomyelitis: neutralizing antibody to TGF-β enhances clinical severity of the disease. J. Neuroimmunol. 47:1993;1-8.
15. Kalland T. Regulation of natural killer progenitors. Studies with a novel immunomodulator with distinct effects at the precursor level. J. Immunol. 144:1990;4472-4476.
16. Karpus W.J., Gould K.E., Swanborg R.H. CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Neurosci. 22:1992;1757-1763.
17. Karussis D.M., Lehmann D., Slavin S., Vourka-Karussis U., Mizrachi-Koll R., Ovadia H., Ben-Nun A., Kalland T., Abramsky O. Inhibition of acute experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide. Ann. Neurol. 34:1993;654-660.
18. Karussis D.M., Lehmann D., Brenner T., Wirguin I., Mizrachi-Koll R., Sicssic C., Abramsky O. Immunomodulation of experimental autoimmune myasthenia gravis with linomide. J. Neuroimmunol. 55:1994;187-193.
19. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4 and prostaglandin E in the brain. J. Exp. Med. 176:1992;1355-1364.
20. Larsson E.L., Joki A., Stalhandske T. Mechanism of action of the new immunomodulator LS2616 on T cell responses. Int. J. Immunopharmacol. 9:1987;425-431.
21. Lehmann D., Karussis D.M., Fluresco D., Mizrachi-Koll R., Ovadia H., Shezen E., Kalland T., Abramsky O. Immunomodulation of autoimmunity by Linomide: inhibition of antigen presentation through down regulation of macrophage activity in the model of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 74:1997;102-110.
22. Lublin F.D. Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity. Curr. Opin. Neurol. Neurosurg. 5:1992;182-187.
23. McKnight A.J., Barclay A.N., Mason D.W. Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells. Eur. J. Immunol. 21:1991;1187-1194.
24. McMaster W.R., Williams A.F. Identification of Ia glycoprotein in rat thymus and purification from rat spleen. Eur. J. Immunol. 9:1979;426-433.
25. Moore K.W., Vieia P., Fiorentino D.F., Trounsteine M.L., Khan T.A., Mosmann T.R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science. 248:1990;1230-1234.
26. Olsson T., Wang W.-Z., Höjeberg B., Kostulas V., Jiang Y.-P., Andersson G., Ekre H.-P., Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen induced secretion of interferon-gamma. J. Clin. Invest. 86:1990;981-985.
27. Racke M.K., Bonomo A., Scott D.E., Cannella B., Levine A., Raine C.S., Shevach E.M., Röcken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1994;1961-1966.
28. Rott O., Fleischer B., Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1994;1434-1440.
29. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheid E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
30. Satoh J., Sakai K., Endoh M., Koike F., Kunishita T., Namikawa T., Yamamura T., Tabira T. Experimental allergic encephalomyelitis mediated by murine encephalitogenic T cell lines specific for myelin proteolipid apaprotein. J. Immunol. 138:1987;179-184.
31. Shirai T., Shimizu N., Horiguchi S., Ito H. Rat TNF alpha. Agric. Biol. Chem. 53:1989;1733-1736.
32. Shirkey B.L., Slavin S., Vistica B.P., Podgor M.J., Gery I. Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functions. Clin. Exp. Immunol. 108:1997;539-544.
33. Tarkowski A., Gunnarsson K., Nilsson L.A., Lindholm L., Stalhandske T. Successful treatment of autoimmunity in MPL/lpr mice with LS-2616, a new immunomodulator. Arthritis Rheum. 29:1986;1405-1409.
34. van der Meide P.H., Dubbeld M., Vijverberg K., Kos T., Schellekens H. The purification of rat gamma interferon by use of two monoclonal antibodies. J. Gen. Virol. 67:1986;1059-1071.
35. Voorthuis J.A.C., Uitdenhaag B.M.J., de Groot C.J.A., Goede H.P., van der Meide P.H., Dijkstra C.D. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin. Exp. Immunol. 81:1990;183-188.
36. Williams A.F., Galfre G., Milstein C. Analysis of cell surface by enogeneic myeloma hybrid antibodies: differentiation antigens of rat lymphocytes. Cell. 12:1987;663-673.
37. Zhu J., Mix E., Olsson T., Link H. Cellular mRNA expression of interferon-γ, interleukin 4 and transforming growth factor-β by rat mononuclear cells stimulated with peripheral nerve antigens in experimental allergic neuritis. Clin. Exp. Immunol. 98:1994;306-312.
38. Zhu J., Mix E., Issazadeh S., Link H. Dynamics of mRNA expression of interferon-γ, interleukin 4 and transforming growth factor β in sciatic nerve and lymphoid organs in experimental allergic neuritis. Eur. J. Neurol. 3:1996;232-240.